Skip to content
Research Article Open access CC BY 3.0

Study of the Hypoglycemic Effect of Tamarindus indica Linn. Seeds on Non-Diabetic and Diabetic Model Rats

Anzana Parvin, Md. Morshedul Alam, Md. Anwarul Haque, Amrita Bhowmik, Liaquat Ali, Begum Rokeya

Journal of Pharmaceutical Research International · pp. 1094–1105 · Published 6 Sep 2013

10.9734/BJPR/2013/4865

Abstract

Aim: The present study was undertaken to evaluate the antidiabetic effects of the Tamarindus indica Linn seed in normal (non-diabetic), type-I and type-II model rats and to investigate their effect on gastrointestinal motility and intestinal glucose absorption. Methodology: T. indica seed powder was used at a dose of 1.25g/kg bw/10 ml water. Male Long-Evans rats (160-210g body weight) were used for the experiment. Experiments were done in non-diabetic and streptozotocin-induced diabetic model rats with a single feeding in different prandial states and blood was collected. An intestinal perfusion technique was used to study the effects of T. indica seed powder on intestinal glucose absorption in normal and type-II model rats. Gut motility was evaluated using barium sulfate milk. Glucose was measured by Glucose oxidase-peroxidase (GOD-POD) method. Result: The screening results showed that T. indica seed powder had no effect on fasting or postprandial serum glucose level of normal and type-I diabetic rat. The seed powder also showed no hypoglycemic effect in the fasting state and no antihyperglycemic effect in type-II model rats when fed simultaneously with oral glucose load, but it exhibited significant antihyperglycemic effect when the seed powder was fed 30 minutes prior to the glucose load at 105 minutes (p<0.03). Glibenclamide significantly lowered postprandial serum glucose levels of non-diabetic and type-II diabetic model rats (p<0.02-0.001). T. indica exerted inhibition on glucose absorption in type-II rats during the whole perfusion period when compared with control. On the other hand, T. indica seed powder significantly inhibited the gastrointestinal motility in type-II rats. Conclusion: The present data suggest that T. indica possesses antihyperglycemic properties in type-II rats which are at least partly due to its inhibitory effect on intestinal glucose absorption. This effect cannot be attributed to the acceleration of intestinal transit.

Anti-hyperglycemic Tamarindus indica streptozotocin type-I diabetes type-II diabetes gastro intestine.

Cited by 7

References

· Plants with Anti-Diabetes Mellitus Properties · 2016

A Scientific Evidence-based Review of Tamarind usage in Indian Folklore Medicine

Mohan Maruga Raja, S. Poonguzhali, Bhagya V. Rao · Journal of Natural Remedies · 2022

Putative antidiabetic herbal food ingredients: Nutra/functional properties, bioavailability and effect on metabolic pathways

Isra Ismail Iid, Satish Kumar, Swati Shukla · Trends in Food Science & Technology · 2020

Diabetes Mellitus Management: An Extensive Review of 37 Medicinal Plants

Khwaja Zohura Zanzabil, Md. Sabbir Hossain, Md. Kamrul Hasan · Diabetology · 2023

Tamarindus indica sub-products as potential tools for simultaneous management of diabetes and obesity

Gustavo Henrique Souza, Beatriz Paes Silva, Gabriel Arcanjo Viana Neto · Food & Function · 2025

References

· Anti-Diabetes Mellitus Plants · 2016

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

7

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.